BridgeBio Oncology Therapeutics, Inc
Price
FilingsNewest: 8-K, Other eventsSep 8 →InsidersNo open-market buys or sales.→HoldersCormorant 22.3%Deerfield 6.1%Omega Fund 4.1%→Financing →PeersClosest companies: BBIO, ROIV, CLYM→
From the filings
Figures
- Net income
- −$182.1Mlast 12 months
- Operating cash flow
- −$130.2Mlast 12 months
- Cash and equivalents
- $54.1Mat the last balance sheet
- Shares outstanding
- 80.1M shareson issue